Jane Street’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-294,318
Closed -$753K 6305
2025
Q1
$753K Buy
294,318
+180,702
+159% +$463K ﹤0.01% 3403
2024
Q4
$214K Buy
113,616
+67,664
+147% +$127K ﹤0.01% 5024
2024
Q3
$46.9K Sell
45,952
-244,307
-84% -$249K ﹤0.01% 5620
2024
Q2
$340K Buy
290,259
+261,338
+904% +$306K ﹤0.01% 4901
2024
Q1
$36.4K Buy
28,921
+96
+0.3% +$121 ﹤0.01% 5450
2023
Q4
$51.3K Buy
+28,825
New +$51.3K ﹤0.01% 5395
2023
Q3
Sell
-276,082
Closed -$552K 5573
2023
Q2
$552K Buy
276,082
+236,417
+596% +$473K ﹤0.01% 3667
2023
Q1
$83.3K Sell
39,665
-52,554
-57% -$110K ﹤0.01% 5004
2022
Q4
$126K Buy
92,219
+13,743
+18% +$18.8K ﹤0.01% 4608
2022
Q3
$82K Sell
78,476
-5,080
-6% -$5.31K ﹤0.01% 4961
2022
Q2
$91K Sell
83,556
-61,652
-42% -$67.1K ﹤0.01% 4773
2022
Q1
$154K Buy
145,208
+59,550
+70% +$63.2K ﹤0.01% 4827
2021
Q4
$71K Buy
85,658
+44,709
+109% +$37.1K ﹤0.01% 4770
2021
Q3
$54K Buy
40,949
+9,284
+29% +$12.2K ﹤0.01% 4868
2021
Q2
$60K Sell
31,665
-16,663
-34% -$31.6K ﹤0.01% 4903
2021
Q1
$215K Buy
48,328
+26,110
+118% +$116K ﹤0.01% 4223
2020
Q4
$81K Buy
22,218
+7,557
+52% +$27.6K ﹤0.01% 3683
2020
Q3
$57K Sell
14,661
-129,160
-90% -$502K ﹤0.01% 3551
2020
Q2
$542K Buy
143,821
+93,469
+186% +$352K ﹤0.01% 2465
2020
Q1
$124K Buy
50,352
+17,528
+53% +$43.2K ﹤0.01% 3049
2019
Q4
$105K Buy
32,824
+31,291
+2,041% +$100K ﹤0.01% 3093
2019
Q3
$3K Sell
1,533
-1,420
-48% -$2.78K ﹤0.01% 3353
2019
Q2
$14K Buy
+2,953
New +$14K ﹤0.01% 3447
2019
Q1
Sell
-7,871
Closed -$24K 3625
2018
Q4
$24K Buy
7,871
+2,190
+39% +$6.68K ﹤0.01% 3083
2018
Q3
$41K Buy
5,681
+1,174
+26% +$8.47K ﹤0.01% 3352
2018
Q2
$19K Buy
4,507
+877
+24% +$3.7K ﹤0.01% 3172
2018
Q1
$20K Sell
3,630
-153
-4% -$843 ﹤0.01% 3020
2017
Q4
$25K Sell
3,783
-707
-16% -$4.67K ﹤0.01% 2987
2017
Q3
$26K Sell
4,490
-2,359
-34% -$13.7K ﹤0.01% 2796
2017
Q2
$57K Sell
6,849
-11,868
-63% -$98.8K ﹤0.01% 2744
2017
Q1
$255K Sell
18,717
-20,059
-52% -$273K ﹤0.01% 2357
2016
Q4
$173K Buy
38,776
+37,397
+2,712% +$167K ﹤0.01% 2392
2016
Q3
$8K Buy
1,379
+18
+1% +$104 ﹤0.01% 2674
2016
Q2
$9K Sell
1,361
-2,509
-65% -$16.6K ﹤0.01% 2543
2016
Q1
$33K Sell
3,870
-10,293
-73% -$87.8K ﹤0.01% 2485
2015
Q4
$144K Buy
14,163
+10,012
+241% +$102K ﹤0.01% 2419
2015
Q3
$49K Sell
4,151
-8,021
-66% -$94.7K ﹤0.01% 2375
2015
Q2
$237K Buy
12,172
+10,677
+714% +$208K ﹤0.01% 2085
2015
Q1
$27K Sell
1,495
-3,445
-70% -$62.2K ﹤0.01% 2107
2014
Q4
$91K Buy
4,940
+1,535
+45% +$28.3K ﹤0.01% 1693
2014
Q3
$82K Buy
3,405
+1,962
+136% +$47.2K ﹤0.01% 2036
2014
Q2
$53K Buy
1,443
+367
+34% +$13.5K ﹤0.01% 2138
2014
Q1
$49K Buy
1,076
+3
+0.3% +$137 ﹤0.01% 2306
2013
Q4
$42K Buy
+1,073
New +$42K ﹤0.01% 1982
2013
Q3
Sell
-1,298
Closed -$64K 2715
2013
Q2
$64K Buy
+1,298
New +$64K ﹤0.01% 2195